keyword
Keywords Gastrointestinal mesenchymal n...

Gastrointestinal mesenchymal neoplasm

https://read.qxmd.com/read/38634092/duodenal-gastrointestinal-stromal-tumor-presenting-with-life-threatening-upper-gi-bleeding-in-a-young-patient-a-case-report-and-literature-review
#1
Samuel Addisu Abera, Amanuel Kassa Tadesse, Kirubel Addisu Abera, Kassa Berie Zegeye, Mohammed Alemu Ibrahim, Ashenafi Amsalu Feleke, Cheru Lilay Gebrehiwet, Segenet Bizuneh Mengistu, Hirut Tesfahun Alemu, Yohannis Derbew Molla
KEY CLINICAL MESSAGE: Duodenal GISTs are rare and challenging tumors. Acute life-threatening upper GI bleeding is a possible presentation of duodenal GISTs. Surgery is the standard treatment for localized duodenal GISTs. Imatinib is an effective adjuvant therapy for duodenal GISTs. ABSTRACT: GIST is the most common mesenchymal neoplasm of the gastrointestinal tract, accounting for 1%-2% of gastrointestinal tumors. They originate from the interstitial cells of Cajal and are rare in patients younger than 30 years...
April 2024: Clinical Case Reports
https://read.qxmd.com/read/38606109/case-report-detection-of-multiple-sporadic-gastrointestinal-stromal-tumors-by-dual-time-18-f-fdg-pet-ct
#2
Chuan Li, Wenxin Li, Maocai Shang, Pan Wang, Xianwen Hu
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors affecting the gastrointestinal tract. Typically, GISTs are solitary; however, in rare cases, they may be multiple and appear in one or more organs. Multiple GISTs can appear in familial GISTs, children, or certain tumor syndromes such as neurofibromatosis type 1, Carney syndrome, and Carney-Stratakis syndrome. However, the diagnosis of primary multiple sporadic GISTs is often more difficult than that of these diseases. Herein, we report a case of multiple primary sporadic GISTs in a 64-year-old man, affecting the abdominal cavity and retroperitoneum, as identified through dual-time point positron emission tomography (PET) with 18 F-labeled fluoro-2-deoxyglucose (18 F-FDG) and computed tomography (18 F-FDG PET/CT)...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38599735/-intestinal-calcifying-fibrous-tumor-case-report
#3
Gonzalo Nathaniel Cantú-Soriano, Álvaro Lezid Padilla-Rodríguez
Calcifying fibrous tumor (CFT) is a rare benign lesion of mesenchymal origin that may present similar characteristics to other more common tumors. We present the case of a 36-year-old woman with a tumor in the proximal jejunum, initially suspected to be a gastrointestinal stromal tumor (GIST). Surgical resection was performed, revealing a well-demarcated nodule at the anti-mesenteric border with microscopic features typical of a calcifying fibrous tumor. The tumor cells were positive for CD34 and negative for other markers, differentiating it from other neoplasms...
2024: Revista Española de Patología
https://read.qxmd.com/read/38584487/expression-of-tgf-%C3%AE-1-in-gastrointestinal-stromal-tumor-gist-and-the-occurrence-of-frequent-desmoplasia
#4
JOURNAL ARTICLE
Kunio Mochizuki, Naoki Oishi, Ippei Tahara, Tomohiro Inoue, Tetsuo Kondo
Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms with variable behavior characterized by differentiation toward the interstitial cells of Cajal occurring anywhere in the gastrointestinal stromal tract. Frequently, GISTs have fibrous stroma within tumor cell proliferation areas, which is unlike other types of malignant tumors. If this desmoplasia is active, there is a possibility that some sort of transmitter exists between GIST cells and cells related to fibrosis in the tumor cell proliferation areas...
April 8, 2024: Applied Immunohistochemistry & Molecular Morphology: AIMM
https://read.qxmd.com/read/38577446/cald1-facilitates-epithelial-mesenchymal-transition-progression-in-gastric-cancer-cells-by-modulating-the-pi3k-akt-pathway
#5
JOURNAL ARTICLE
Wen-Qian Ma, Ming-Chang Miao, Ping-An Ding, Bi-Bo Tan, Wen-Bo Liu, Shuo Guo, Li-Mian Er, Zhi-Dong Zhang, Qun Zhao
BACKGROUND: CALD1 has been discovered to be abnormally expressed in a variety of malignant tumors, including gastric cancer (GC), and is associated with tumor progression and immune infiltration; however, the roles and mechanisms of CALD1 in epithelial-mesenchymal transition (EMT) in GC are unknown. AIM: To investigate the role and mechanism of CALD1 in GC progression, invasion, and migration. METHODS: In this study, the relationship between CALD1 and GC, as well as the possible network regulatory mechanisms of CALD1, was investigated by bioinformatics and validated by experiments...
March 15, 2024: World Journal of Gastrointestinal Oncology
https://read.qxmd.com/read/38505598/preoperative-differentiation-of-gastric-schwannomas-and-gastrointestinal-stromal-tumors-based-on-computed-tomography-a-retrospective-multicenter-observational-study
#6
JOURNAL ARTICLE
Luping Zhao, Guanjie Cao, Zhitao Shi, Jingjing Xu, Hao Yu, Zecan Weng, Sen Mao, Yueqin Chen
INTRODUCTION: Gastric schwannoma is a rare benign tumor accounting for only 1-2% of alimentary tract mesenchymal tumors. Owing to their low incidence rate, most cases are misdiagnosed as gastrointestinal stromal tumors (GISTs), especially tumors with a diameter of less than 5 cm. Therefore, this study aimed to develop and validate a diagnostic nomogram based on computed tomography (CT) imaging features for the preoperative prediction of gastric schwannomas and GISTs (diameters = 2-5 cm)...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38485843/gastric-inflammatory-myofibroblastic-tumor-a-case-report
#7
JOURNAL ARTICLE
Taku Hattori, Yutaka Tanizawa, Tadakazu Shimoda, Yusuke Koseki, Kenichiro Furukawa, Keiichi Fujiya, Daisuke Aizawa, Takashi Sugino, Masanori Terashima, Etsuro Bando
BACKGROUND: Inflammatory myofibroblastic tumor (IMT) of the stomach is an uncommon mesenchymal neoplasm. We present a case of gastric submucosal tumor (SMT) where the final diagnosis was IMT. CASE PRESENTATION: A 69-year-old man presented with a 24-mm SMT on the posterior wall of the middle third of the stomach that was detected by screening upper gastrointestinal endoscopy. Abdominal contrast-enhanced computed tomography showed that the tumor was well-enhanced...
March 15, 2024: Surgical Case Reports
https://read.qxmd.com/read/38482242/prognostic-nomogram-in-patients-with-gastrointestinal-stromal-tumors-a-seer-based-study
#8
JOURNAL ARTICLE
Pan Xu, Wei Ding, Feifei Zheng, Tingyan Ruan, Jing Liu, Junli Ding, Junying Xu
BACKGROUND: Gastrointestinal stromal tumor (GIST) is a common mesenchymal tumor of the gastrointestinal system. They originate from the interstitial cells of Cajal located within the muscle layer and are characterized by over-expression of the tyrosine kinase receptor KIT. METHODS: Data from the Surveillance Epidemiology, and End Results (SEER) database of 1,213 patients diagnosed with GIST between 2010 and 2019 were dichotomized into a modeling set and a validation set at a 2:1 ratio...
February 29, 2024: Journal of Gastrointestinal Oncology
https://read.qxmd.com/read/38472638/solitary-fibrous-tumor-occurring-in-the-colon-as-submucosal-mesenchymal-lesion-report-of-two-cases-and-review-of-the-literature
#9
REVIEW
Muhammad Akrmah, Elsayed Ibrahim, Laila Omar Mnayer, Saverio Ligato
Solitary fibrous tumor (SFT) is a rare mesenchymal neoplasm most often arising from the pleura and rarely in extra-pleural locations, including the gastrointestinal tract. We describe two cases of a SFT presenting as submucosal colonic lesion and review the literature on this lesion. One submucosal lesion was localized in the cecum and was 10 mm in size. The second lesion presented as a 17 mm submucosal rectal lesion. Both lesions presented as well-circumscribed submucosal lesions arranged in short fascicles, blending with abundant collagenous stroma...
March 12, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38463229/intercellular-crosstalk-between-cancer-cells-and-cancer-associated-fibroblasts-via-exosomes-in-gastrointestinal-tumors
#10
REVIEW
Longyang Cao, Hong Ouyang
Gastrointestinal (GI) tumors are a significant global health threat, with high rates of morbidity and mortality. Exosomes contain various biologically active molecules like nucleic acids, proteins, and lipids and can serve as messengers for intercellular communication. They play critical roles in the exchange of information between tumor cells and the tumor microenvironment (TME). The TME consists of mesenchymal cells and components of the extracellular matrix (ECM), with fibroblasts being the most abundant cell type in the tumor mesenchyme...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38455132/endoscopic-resection-for-calcifying-fibrous-tumors-of-the-gastrointestinal-tract
#11
JOURNAL ARTICLE
Zi-Han Geng, Yan Zhu, Pei-Yao Fu, Yi-Fan Qu, Shi-Yao Chen, Yun-Shi Zhong, Yi-Qun Zhang, Wei-Feng Chen, Wen-Zheng Qin, Jian-Wei Hu, Ming-Yan Cai, Li-Qing Yao, Quan-Lin Li, Ping-Hong Zhou
BACKGROUND: Calcifying fibrous tumors (CFTs) are rare mesenchymal lesions that can occur in various sites throughout the body, including the tubular gastrointestinal (GI) tract. AIM: To analyze the clinical findings of 36 patients with GI tract CFTs to provide guidance for diagnosis and treatment. METHODS: This retrospective study included 36 patients diagnosed with CFTs of the GI tract. We collected demographic and clinical information and conducted regular follow-ups to assess for local recurrence...
February 24, 2024: World Journal of Clinical Oncology
https://read.qxmd.com/read/38435882/a-case-of-gastrointestinal-stromal-tumour-gist-in-the-duodenum-in-a-young-adult
#12
Dinesh Abhijeeth Shanker, Sampath Kumar, Ahmed Al-Mukhtar, Asha Dube, Nehemiah Samuel
Gastrointestinal stromal tumours (GISTs) are rare gastrointestinal (GI) malignancies, but the most prevalent mesenchymal tumours of the GI tract arise from the interstitial cells of Cajal. They account for 1-3% of all GI malignancies, and only 3-5% of all cases of GIST are located at the duodenal. We present a case of a young adult who presented to the ED with symptoms of GI bleeding.
January 2024: Curēus
https://read.qxmd.com/read/38427771/hepatic-and-perihepatic-pecomas-a-study-describing-a-series-of-five-rare-cases
#13
JOURNAL ARTICLE
P Vijayanirmala, Rajni Yadav, Surbhi Goyal, Adarsh Barwad, Subham Bhowmik, Rohan Malik, Sujoy Pal, Raju Sharma, Puja Sakhuja, Prasenjit Das
BACKGROUND: Perivascular epithelioid cell tumors (PEComas) encompass a group of rare mesenchymal neoplasms, with dual melanocytic and muscular differentiation. Hepatic PEComas are rare and difficult to diagnose, and their behavior is still unclear. MATERIALS AND METHODS: Herein, we report a total of five cases of hepatic and perihepatic PEComas over a period of the last 5 years from our and collaborating center's archive. A detailed histological evaluation was done...
February 19, 2024: Indian Journal of Pathology & Microbiology
https://read.qxmd.com/read/38425409/global-research-trends-and-prospects-of-cellular-metabolism-in-colorectal-cancer
#14
JOURNAL ARTICLE
Yan-Chen Liu, Zhi-Cheng Gong, Chao-Qun Li, Peng Teng, Yan-Yan Chen, Zhao-Hui Huang
BACKGROUND: An increasing number of studies have focused on the role of cellular metabolism in the development of colorectal cancer (CRC). However, no work is currently available to synthesize the field through bibliometrics. AIM: To analyze the development in the field of "glucose metabolism" (GM), "amino acid metabolism" (AM), "lipid metabolism" (LM), and "nucleotide metabolism" (NM) in CRC by visualization. METHODS: Articles within the abovementioned areas of GM, AM, LM and NM in CRC, which were published from January 1, 1991, to December 31, 2022, are retrieved from the Web of Science Core Collection and analyzed by CiteSpace 6...
February 15, 2024: World Journal of Gastrointestinal Oncology
https://read.qxmd.com/read/38408159/pediatric-plexiform-fibromyxoma-a-case-report
#15
JOURNAL ARTICLE
Patricia Bugeda Gómez, Adrià Costa-Roig, Carolina Montecino Romanini, Ignacio Miró Rubio, Santiago Guindos Rúa, Diana C Lara Cárdenas, Micaela Germani, María Roca Roca, Cleofe Romagosa Pérez Portabella, Marta Garrido Pontnou, Javier Hernández Losa, Luis F Sanchís Solera
The plexiform fibromyxoma is a rare mesenchymal tumor in adults that generally originates in the antrum of stomach, being its occurrence in pediatric patients exceptional. It was classified as a distinct entity by World Health Organization in 2010. No recurrences and metastases have been documented in many of the reported patients to date, being the surgical treatment curative. We report the case of a 3-month-old infant who presented to the emergency department with an episode of intestinal subocclusion requiring an emergent surgery...
February 26, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38401916/precision-oncology-in-soft-tissue-sarcomas-and-gastrointestinal-stromal-tumors
#16
REVIEW
Adam M Fontebasso, Jeffrey D Rytlewski, Jean-Yves Blay, Rebecca A Gladdy, Breelyn A Wilky
Soft tissue sarcomas (STSs), including gastrointestinal stromal tumors (GISTs), are mesenchymal neoplasms with heterogeneous clinical behavior and represent broad categories comprising multiple distinct biologic entities. Multidisciplinary management of these rare tumors is critical. To date, multiple studies have outlined the importance of biological characterization of mesenchymal tumors and have identified key molecular alterations which drive tumor biology. GIST has represented a flagship for targeted therapy in solid tumors with the advent of imatinib which has revolutionized the way we treat this malignancy...
April 2024: Surgical Oncology Clinics of North America
https://read.qxmd.com/read/38396207/gastrointestinal-stromal-tumors-in-fine-needle-aspiration-biopsies
#17
JOURNAL ARTICLE
Seyedreza Mousavi, Yuho Ono, Paul A VanderLaan, Yaileen D Guzmán-Arocho
Gastrointestinal stromal tumors (GISTs), although rare, are the most common mesenchymal neoplasms of the gastrointestinal tract. Their potential for malignancy underscores the significance of identifying them through cytomorphologic findings and pertinent immunohistochemical markers. GISTs can emerge anywhere along the gastrointestinal tract with a predilection for the stomach. The clinical manifestations vary from nonspecific abdominal symptoms to incidental discovery during diagnostic interventions for unrelated signs and symptoms...
February 23, 2024: Diagnostic Cytopathology
https://read.qxmd.com/read/38395931/clinical-characteristics-and-prognostic-analysis-of-postoperative-recurrence-or-metastasis-of-low-risk-gastrointestinal-stromal-tumors
#18
JOURNAL ARTICLE
Lianlian Cao, Chen Lin, Yu Liu, Chao Sui, Zhaoping Li, Li Chen, Wenxian Guan, Liang Tao, Tingting Tao, Meng Wang, Feng Wang
BACKGROUND: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive tract. This study aimed to investigate the clinical characteristics and prognosis of postoperative recurrence or metastasis in patients with low-risk stromal tumors, in order to take individualized postoperative management and treatment for patients with low-risk GISTs with relatively high recurrence. METHODS: We retrospectively analyzed the clinicopathological and follow-up data of patients with GISTs who underwent surgical resection in Nanjing Drum Tower Hospital from March 2010 to December 2021...
February 23, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38350902/olfm2-promotes-epithelial-mesenchymal-transition-migration-and-invasion-in-colorectal-cancer-through-the-tgf-%C3%AE-smad-signaling-pathway
#19
JOURNAL ARTICLE
Yong Tang, Yi Liu, Xiaobo Wang, Haiyang Guo, Lin Chen, Guangbing Hu, Yutong Cui, Shiqi Liang, Ji Zuo, Zichen Luo, Xinrui Chen, Xianfei Wang
BACKGROUND: Colorectal cancer (CRC) is an aggressive tumor of the gastrointestinal tract, which is a major public health concern worldwide. Despite numerous studies, the precise mechanism of metastasis behind its progression remains elusive. As a member of the containing olfactomedin domains protein family, olfactomedin 2 (OLFM2) may play a role in tumor metastasis. It is highly expressed in colorectal cancer, and its role in the metastasis of CRC is still unclear. As such, this study seeks to explore the function of OLFM2 on CRC metastasis and its potential mechanisms...
February 13, 2024: BMC Cancer
https://read.qxmd.com/read/38336371/multiomic-molecular-characterization-of-the-response-to-combination-immunotherapy-in-mss-pmmr-metastatic-colorectal-cancer
#20
JOURNAL ARTICLE
Shogo Takei, Yosuke Tanaka, Yi-Tzu Lin, Shohei Koyama, Shota Fukuoka, Hiroki Hara, Yoshiaki Nakamura, Yasutoshi Kuboki, Daisuke Kotani, Takashi Kojima, Hideaki Bando, Saori Mishima, Toshihide Ueno, Shinya Kojima, Masashi Wakabayashi, Naoya Sakamoto, Motohiro Kojima, Takeshi Kuwata, Takayuki Yoshino, Hiroyoshi Nishikawa, Hiroyuki Mano, Itaru Endo, Kohei Shitara, Akihito Kawazoe
BACKGROUND: Immune checkpoint inhibitor (ICI) combinations represent an emerging treatment strategies in cancer. However, their efficacy in microsatellite stable (MSS) or mismatch repair-proficient (pMMR) colorectal cancer (CRC) is variable. Here, a multiomic characterization was performed to identify predictive biomarkers associated with patient response to ICI combinations in MSS/pMMR CRC for the further development of ICI combinations. METHODS: Whole-exome sequencing, RNA sequencing, and multiplex fluorescence immunohistochemistry of tumors from patients with MSS/pMMR CRC, who received regorafenib plus nivolumab (REGONIVO) or TAS-116 plus nivolumab (TASNIVO) in clinical trials were conducted...
February 8, 2024: Journal for Immunotherapy of Cancer
keyword
keyword
17624
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.